Inside Precision Medicine June 16, 2025
Anne Wojcicki, co-founder and former CEO of direct-to-consumer genetic testing company 23andMe, has succeeded in a bid to buy almost all the assets of the bankrupt company through a nonprofit set up by Wojcicki in May this year called TTAM.
TTAM has undeclared backers in industry, and according to its website “is a nonprofit medical research organization dedicated to helping scientists and non-scientists join together to unravel the mysteries of DNA.”
The bid of $305 million includes 23andMe’s core genetic testing and telehealth businesses and surpassed a previous bid from Regeneron Pharmaceuticals of $256 million made last month.
For the acquisition to go through, the U.S. Bankruptcy Court for the Eastern District of Missouri needs to approve the sale and...
Today's Sponsors
Today's Sponsor